The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

Key Changes in Pediatric Resuscitation in 2025

The ERC’s 2025 pediatric resuscitation update simplifies airway management, drug dosing, and post-ROSC care to help teams act faster in emergencies.

Daptomycin, Linezolid Use Safe From Resistance Rise

Increased daptomycin and linezolid use is not linked to clinically significant increases in resistance in Gram-positive bacteria over 8 years, study suggests.

Mild TBI Mortality Reaches 13.6% at 12 Months

Death rate in patients with mild TBI is 13.6% at 12 months; patients with Glasgow Coma Scale scores of 13-14 have a higher death risk than those with score 15, a study shows.

GLP-1s May Improve Inflammation, Anemia in Dialysis Patients

In patients undergoing hemodialysis, GLP-1 RA use is associated with lower levels of inflammatory markers and lower requirements for anemia medications.

Medscape State of the Medical Profession Index Report 2026

Doctors’ satisfaction with how the medical profession is tackling issues such as patient care and recruitment, as well as their optimism for progress, may reflect an industry at a crossroads.

Fluoroquinolone Cross-Reactions Rare, Vary by Drug Pair

A fluoroquinolone allergy label rarely predicts a cross-drug reaction to another fluoroquinolone, with most reactions occurring within a year of the initial allergy.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Todays Updates

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Black Canadians Face Multiple Barriers to Blood Donation

Barriers to blood donations from Black people in Canada are rooted in racism and restrictive policies.

Can Accelerated Salvage RT Improve Prostate Cancer Control?

After biochemical recurrence, hypofractionated RT may be no more effective than standard RT for disease control — and may have more late side effects.

Laser Therapy Shows Promise for Brain Tumors

Researchers followed 787 patients with brain tumors treated with laser therapy for up to 5 years.

Ibrutinib Fails in High-Risk Early-Stage CLL

Ibrutinib improves event-free survival in certain genetic subgroups of early-stage chronic lymphocytic leukemia but fails to extend overall survival.

Latest News

The ERC’s 2025 pediatric resuscitation update simplifies airway management, drug dosing, and post-ROSC care to help teams act faster in emergencies.

Increased daptomycin and linezolid use is not linked to clinically significant increases in resistance in Gram-positive bacteria over 8 years, study suggests.

Death rate in patients with mild TBI is 13.6% at 12 months; patients with Glasgow Coma Scale scores of 13-14 have a higher death risk than those with score 15, a study shows.

In patients undergoing hemodialysis, GLP-1 RA use is associated with lower levels of inflammatory markers and lower requirements for anemia medications.

Doctors’ satisfaction with how the medical profession is tackling issues such as patient care and recruitment, as well as their optimism for progress, may reflect an industry at a crossroads.

A fluoroquinolone allergy label rarely predicts a cross-drug reaction to another fluoroquinolone, with most reactions occurring within a year of the initial allergy.

News All Time

What to Know About US Measles Cases on the Rise

Two Pennsylvania residents have died due to measles, health officials said on Tuesday, the first U.S. deaths from the disease reported in 2026 and the first in the state in...

FDA Approves Continuous Glucose + Ketone Monitor Device

The Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System was authorized for people ages 2 years and older with diabetes.

First-Line Biologics May Aid Remission in Still Disease

First-line biologic therapy is associated with higher rates of sustained event-free remission than nonbiologic immune modulators in adult-onset Still disease.

‘Getting Them From All Over’: Microplastics and Rheumatology

A growing body of evidence suggests that microplastics not only accumulate in the body but may have damaging effects, including for people with rheumatic diseases.

Racial Disparities Tied to Resolution of Food Allergy

Race and parental health literacy affect the likelihood of outgrowing food allergies in children, with historically marginalized groups showing the lowest odds of resolution.

Deep Dive: H2 Blockers: Ranitidine's Return

Five years after an NDMA-driven withdrawal, ranitidine has FDA approval again. A practical guide to all four H2 blockers, and where each still fits.

Anifrolumab vs Belimumab in Lowering SLE Cardiovascular Risk

Anifrolumab treatment is associated with a lower risk for cardiovascular disease than belimumab treatment in patients with systemic lupus erythematosus.

Clinical Pearls for Managing Insect Bites

Multiple factors play a role in the differential diagnosis of insect bites, including lesion distribution, exposure history, geographic location, pets, and travel history.

Bariatric Surgery Isn’t for Everyone. It Was for Her

Bariatric surgery requires discipline, before and after the procedure. One New Hampshire woman shares what it takes.

Severe Burn Care Shifts Beyond Survival

Severe burn care is shifting beyond survival, with specialists now emphasizing functional recovery, quality of life, and long-term follow-up.

Doctors Recall Gironde Wildfire Evacuations

As wildfires swept Gironde, volunteer physicians, nurses, and emergency services rapidly built care pathways for evacuees in makeshift medical stations.

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

(Fixes hyperlink in paragraph 10)

Biphasic Anaphylaxis More Common in Younger Infants

Infants experiencing anaphylaxis display distinct symptoms, complicating timely recognition, with biphasic reactions occurring more often in younger infants.

Why the Brain May Become Our Default Longevity Barometer

Epigenetic clocks can give ‘a vague concept of aging,’ but researchers are progressing to organ-specific techniques that provide actionable, medically meaningful data.

Pediatric Antibiotic Resistance Rising Worldwide

Global pediatric data suggest resistance to last-line antibiotics is climbing fast, with ICU and sepsis cases showing some of the steepest increases.

Meningococcal B Vaccination: Age and Regional Disparities

Meningococcal B vaccination rates for individuals aged 25 years or younger across 10 US health systems vary by location, age, and sex, with more than a third with high-risk conditions receiving doses.

Recommended News For You

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

An understudied type of breast cancer poses a lurking threat

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

Alternative breast imaging techniques beyond mammography.

Does Maintenance Therapy Extend Life in mCRC?

Asandeutertinib Tops Osimertinib for NSCLC With Brain Mets

Recommended Articles For You

Tremelimumab: A Potential Breakthrough in Cancer Treatment 

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies 

Essential Strategies in Hematology for Healthcare Excellence 

An Overview Of Daunorubicin: What Is It Used For And How Does It Work? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

De-escalation Misses the Mark in Inflammatory Breast Cancer

2.

10-year study shows tomosynthesis improves breast cancer detection

3.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

4.

Virtual Help Doubles Cancer Patients’ Smoking Quit Rate

5.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

1.

Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning

2.

Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes

3.

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders

4.

Precision Oncology Using Tumor Evolutionary Trajectory Modeling

5.

Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

2.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

3.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

4.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

5.

Diagnosis and Management in Hematology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot